Home > Healthcare > Medical Services > Inpatient and Outpatient Services > Colorectal Cancer Therapeutics Market
Colorectal Cancer Therapeutics Market Size
- Report ID: GMI9808
- Published Date: Jun 2024
- Report Format: PDF
Colorectal Cancer Therapeutics Market Size
Colorectal Cancer Therapeutics Market size was valued at USD 12.4 billion in 2023 and is poised to expand at over 4.6% CAGR from 2024 to 2032, due to rising incidence rates, advancements in targeted and cancer immunotherapy, and enhanced screening and early detection programs. An aging global population, improved healthcare infrastructure in emerging markets, and increased healthcare expenditure further drive demand. Further, regulatory support and substantial research funding facilitate the development and rapid approval of new treatments, while precision medicine tailors’ therapies to individual genetic profiles, improving patient outcomes.
Colorectal cancer therapeutics refers to the range of medical treatments and interventions used to manage and treat colorectal cancer, which includes cancers of the colon and rectum. These therapeutics aim to eliminate cancer cells, reduce tumor size, prevent cancer recurrence and improve patient survival.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Colorectal Cancer Therapeutics Market Size in 2023: | USD 12.4 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 4.6% |
| 2032 Value Projection: | USD 18.6 Billion |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 114 |
| Tables, Charts & Figures: | 206 |
| Segments covered: | Therapy, Cancer Type, Treatment Provider, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Colorectal Cancer Therapeutics Market Scope
